Loading stock data…
TRUP
$22.17+0.12 (+0.54%)
After Hours$21.82-0.35 (-1.57%)· Last close Jun 9
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Trupanion, Inc. in the Financial Services sector is trading at $22.17. Wall Street consensus targets $39.75 (4 analysts), implying a +79.3% move over the next 12 months. The stock is currently near its 52-week low of $21.16, remaining 33.9% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +79.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$22.17
Potential Downside
0%
Whystock Fair Value$22.17
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.53%
Volume
Today's trading volume
277,075
Recent News
How The Trupanion (TRUP) Investment Narrative Is Evolving Without New Analyst Targets
Trupanion’s latest analyst update comes with no change to the stock’s price target, which keeps the formal outlook exactly where it was before. Even without a fresh target or commentary to unpack, the absence of revisions can still indicate how analysts currently see the risk and reward trade off. As you read on, you will see how to track these kinds of updates so you can follow the evolving narrative around Trupanion more confidently over time. Stay updated as the Fair Value for Trupanion...
1 Insurance Stock on Our Watchlist and 2 Facing Challenges
Insurance companies serve as the backbone of risk management, providing essential protection and financial security for individuals and businesses. But concerns about claims severity and tightening regulations have tempered enthusiasm, and over the past six months, the industry has pulled back by 4.9%. This performance is a stark contrast from the S&P 500’s 11% gain.
Is the Options Market Predicting a Spike in Trupanion Stock?
Investors need to pay close attention to TRUP stock based on the movements in the options market lately.
Zacks Industry Outlook Highlights Aflac, Unum, Globe Life, Trupanion and Employers
Accident and health insurers are gaining from underwriting growth, technology adoption and rising demand for supplemental coverage.
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.